开发列线图对颅内孤立性纤维性肿瘤复发进行分层
列线图在测试队列中3年和5年复发的Harrell C指数分别为0.845和0.807,决策曲线分析显示净临床获益。术后放疗有助于预防复发,但高剂量(≥46 Gy)在延长无进展生存方面并不优于较低剂量。
要点
- 列线图整合临床、影像和病理特征,可用于颅内孤立性纤维性肿瘤复发风险分层。
- 测试队列中列线图预测3年和5年复发的Harrell C指数分别为0.845和0.807。
- 术后放疗有助于预防复发,但高剂量(≥46 Gy)在延长无进展生存方面不优于较低剂量。
核心结论
- 基于临床、影像和病理特征构建的列线图预测性能良好,可用于颅内孤立性纤维性肿瘤患者的复发分层。
临床应用与阅片要点
- 列线图可用于颅内孤立性纤维性肿瘤患者术后复发风险评估;术后放疗有助于预防复发,但高剂量(≥46 Gy)在延长无进展生存方面不优于较低剂量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop a nomogram to stratify tumor recurrence (TR) in intracranial solitary fibrous tumors (ISFTs) based on the clinical, radiological, and pathological features.
MATERIALS AND METHODS: A total of 215 patients from Beijing Tiantan Hospital, Capital Medical University and 48 patients from Lanzhou University Second Hospital, diagnosed with ISFT based on histopathological findings, were included. The patients were randomly divided into training and test cohorts at a ratio of 8:2. Information regarding clinical, radiological, and histopathological features, and the clinical outcomes was retrospectively analyzed. Univariate and multivariate analyses were performed using the Cox proportional hazard model for TR in the training cohort. A nomogram incorporating the independent risk factors was developed in the training cohort and validated in the test cohort. Its predictive performance was analyzed using the Harrell C-index. Decision curve analysis (DCA) was used to evaluate the net clinical benefit.
RESULTS: The Harrell C-indices for TR at 3 and 5 years were 0.845 (0.578-0.944) and 0.807 (0.612-0.901) for the test cohort, respectively. In the test cohort, the nomogram provided a net clinical benefit in the DCA over the TR scheme or non-TR scheme. Although postoperative radiotherapy (PORT) was useful for TR prevention, high doses (≥46 Gy) were not superior to lower doses in prolonging the progression-free survival.
CONCLUSION: The nomogram obtained in our study had a good predictive performance and could be used for ISFT patients.
引用
- Liang X, Ke X, Jiang J, et al. Developing a Nomogram to Stratify Intracranial Solitary Fibrous Tumor Recurrence. Acad Radiol. 2023. PMID: 37741734. doi:10.1016/j.acra.2023.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。